Concepedia

Publication | Closed Access

BCL-2 system analysis identifies high-risk colorectal cancer patients

52

Citations

19

References

2016

Year

Abstract

DR_MOMP delivers a system-based biomarker with significant potential as a prognostic tool for stage III CRC that significantly improves established histopathological risk factors.

References

YearCitations

Page 1